Skip to Content

20/12.5 Logo 5034 (Hydrochlorothiazide and Lisinopril 12.5 mg / 20 mg)

Pill with imprint 20/12.5 Logo 5034 is Yellow, Round and has been identified as Hydrochlorothiazide and Lisinopril 12.5 mg / 20 mg. It is supplied by Teva Pharmaceuticals USA.

Hydrochlorothiazide/lisinopril is used in the treatment of high blood pressure; heart failure and belongs to the drug class ACE inhibitors with thiazides. There is positive evidence of human fetal risk during pregnancy. Hydrochlorothiazide/lisinopril 12.5 mg / 20 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for 20/12.5 Logo 5034

Hydrochlorothiazide and lisinopril 12.5 mg / 20 mg 20/12.5 Logo 5034
Hydrochlorothiazide and lisinopril 12.5 mg / 20 mg 20/12.5 Logo 5034
Hydrochlorothiazide and lisinopril 12.5 mg / 20 mg 20/12.5 Logo 5034

Hydrochlorothiazide and Lisinopril

Imprint:
20/12.5 Logo 5034
Strength:
12.5 mg / 20 mg
Color:
Yellow
Size:
8.00 mm
Shape:
Round
Availability:
Prescription only
Drug Class:
ACE inhibitors with thiazides
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Teva Pharmaceuticals USA
Inactive Ingredients:
calcium phosphate dibasic anhydrous
magnesium stearate
mannitol
corn starch
magnesium silicate
ferric oxide red
ferric oxide yellow
Note: Inactive ingredients may vary.

Other Labelers / Repackagers:

NDC CodeLabeler / Repackager
43063-0065 PDRX Pharmaceuticals Inc. (repackager)

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide